Invesco Biotechnology & Genome ETF Rating $68.84 -0.30 (-0.43%) (As of 12:50 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy2.73Holdings in PBE have an aggregate rating of Moderate Buy based on 389 analyst ratings issued in the past year covering 29 companies (97.3% of the portfolio).PBE Aggregate Price Target$89.0729.35% UpsideHigh Prediction$119.98Average Prediction$89.07Low Prediction$61.34Holdings in PBE have an aggregate price target of $89.07 and a range of $61.34 to $119.98 covering 29 companies (97.3% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.83%ILMNIllumina$153.89+2.8%4.1382 of 5 stars2.67$154.33 0.3%245.23%UTHRUnited Therapeutics$377.58+1.0%4.645 of 5 stars2.73$370.86 -1.8%15Earnings ReportAnalyst ForecastPositive News5.17%ALNYAlnylam Pharmaceuticals$272.00-0.7%3.8177 of 5 stars2.75$294.50 8.3%24Earnings ReportAnalyst Forecast5.08%AMGNAmgen$316.78-0.8%4.5085 of 5 stars2.50$333.50 5.3%24Earnings ReportAnalyst UpgradeAnalyst Revision4.82%BIIBBiogen$174.42+0.4%4.838 of 5 stars2.62$262.83 50.7%26Earnings ReportAnalyst ForecastAnalyst Revision4.32%REGNRegeneron Pharmaceuticals$839.97-0.4%4.8422 of 5 stars2.71$1,097.25 30.6%21Analyst Forecast3.98%BMRNBioMarin Pharmaceutical$66.08-0.8%4.9702 of 5 stars2.67$94.16 42.5%21Earnings ReportAnalyst Revision3.91%NBIXNeurocrine Biosciences$121.43-0.6%4.919 of 5 stars2.83$163.91 35.0%24Analyst ForecastAnalyst Revision3.43%XNCRXencor$21.39+0.6%4.0499 of 5 stars3.00$34.78 62.6%9Upcoming Earnings3.39%MNKDMannKind$7.28+1.5%1.7829 of 5 stars3.14$8.67 19.0%7Upcoming Earnings3.16%NVAXNovavax$9.03-3.4%3.5847 of 5 stars2.33$17.83 97.5%63.06%NTRANatera$124.07-0.1%2.8815 of 5 stars3.00$125.69 1.3%16Insider Selling3.06%PTGXProtagonist Therapeutics$47.69+2.0%3.0072 of 5 stars3.17$52.83 10.8%6Upcoming Earnings2.96%VCYTVeracyte$34.46+0.4%4.2431 of 5 stars2.71$35.67 3.5%7Upcoming Earnings2.90%TECHBio-Techne$75.96+0.9%4.1451 of 5 stars2.67$81.78 7.7%9Earnings ReportDividend AnnouncementAnalyst Upgrade2.85%EXELExelixis$34.54+1.2%4.6521 of 5 stars2.65$31.44 -9.0%20Earnings Report2.81%CPRXCatalyst Pharmaceuticals$21.880.0%4.7913 of 5 stars3.00$29.50 34.8%6Upcoming Earnings2.81%COLLCollegium Pharmaceutical$33.65+0.6%4.1774 of 5 stars2.60$42.60 26.6%5Upcoming EarningsPositive News2.78%INCYIncyte$76.20+0.1%4.0908 of 5 stars2.38$76.74 0.7%21Earnings Report2.76%TGTXTG Therapeutics$24.90-7.4%4.7948 of 5 stars2.83$36.33 45.9%6News CoverageGap Down2.75%CDNACareDx$22.56-0.4%4.0203 of 5 stars2.43$30.60 35.6%72.73%RGENRepligen$138.18-0.3%4.7648 of 5 stars2.80$190.25 37.7%10Positive News2.66%BPMCBlueprint Medicines$92.11+1.6%2.1931 of 5 stars2.70$120.39 30.7%20Earnings ReportAnalyst Revision2.66%ACADACADIA Pharmaceuticals$14.72-0.6%4.5087 of 5 stars2.65$25.56 73.7%17Upcoming Earnings2.55%MYGNMyriad Genetics$17.25-4.1%4.5901 of 5 stars2.42$28.91 67.6%12Upcoming EarningsGap Down2.53%BCRXBioCryst Pharmaceuticals$7.07-16.1%3.9174 of 5 stars2.83$14.17 100.4%6News CoverageGap DownHigh Trading Volume2.49%OPKOPKO Health$1.50-0.7%4.5875 of 5 stars3.00$2.75 83.3%3Upcoming Earnings2.38%HALOHalozyme Therapeutics$58.66+2.6%4.7201 of 5 stars2.60$61.00 4.0%10Analyst Forecast2.19%VCELVericel$44.46+1.1%2.6627 of 5 stars3.00$57.71 29.8%7Upcoming Earnings This page (NYSEARCA:PBE) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
